{"transactions":[{"id":706453,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":29696,"kind":"person","name":"Gengos Andrew","position":1,"cik":"0001563623","reported_name":"Gengos Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-07-17T20:29:06.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continued employment through each applicable vesting date, 8.33333% of the shares underlying the stock option shall vest on each of the first, second and third monthly anniversary of the grant transaction date (the \"Grant Date\"); 1.6667% of the shares underlying the stock option shall vest on the fourth monthly anniversary of the Grant Date and on each monthly anniversary thereafter until the one year anniversary of the Grant Date; 3.33333% of the shares underlying the stock option shall vest on each monthly anniversary following the one-year anniversary of the Grant Date until the second anniversary of the Grant Date; and 0.833333% of the of the shares underlying the stock option shall vest on each monthly anniversary following the second anniversary of the Grant Date until the fourth anniversary of the Grant Date, such that all shares underlying the stock option shall be fully vested on the fourth anniversary of the Grant Date."}],"balance_after":650000,"derivative":{"exercise_price":4.78,"expiration_date":"2036-07-16","underlying":"Class A Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001790340-26-000082","document":"wk-form4_1784320143.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563623/000179034026000082/wk-form4_1784320143.xml","form_type":"4"}},{"id":727849,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":35709,"kind":"person","name":"Zeskind Benjamin J.","position":1,"cik":"0001870062","reported_name":"Zeskind Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:11:29.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":4.5617,"value":10948.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.55 to $4.59. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":2315252,"source":{"system":"sec-edgar","filing":"0001790340-26-000078","document":"wk-form4_1782331885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870062/000179034026000078/wk-form4_1782331885.xml","form_type":"4"}},{"id":735738,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-16T20:15:14.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":6035,"price":4.15,"value":25045.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.146 to $4.15. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":382531,"source":{"system":"sec-edgar","filing":"0001790340-26-000076","document":"wk-form4_1781640910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000076/wk-form4_1781640910.xml","form_type":"4"}},{"id":741513,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:37:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":4.12,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-26-000072","document":"wk-form4_1781213861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034026000072/wk-form4_1781213861.xml","form_type":"4"}},{"id":741237,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39170,"kind":"person","name":"HAUSMAN DIANA","position":1,"cik":"0001563992","reported_name":"HAUSMAN DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:33:19.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":4.12,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-26-000070","document":"wk-form4_1781213596.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563992/000179034026000070/wk-form4_1781213596.xml","form_type":"4"}},{"id":742198,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39425,"kind":"person","name":"CARPENTER ROBERT J","position":1,"cik":"0001021046","reported_name":"CARPENTER ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:29:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":4.12,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-26-000068","document":"wk-form4_1781213381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021046/000179034026000068/wk-form4_1781213381.xml","form_type":"4"}},{"id":741668,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":27196,"kind":"person","name":"KEATING LAURIE","position":1,"cik":"0001620743","reported_name":"KEATING LAURIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:26:15.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":4.12,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-26-000066","document":"wk-form4_1781213173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620743/000179034026000066/wk-form4_1781213173.xml","form_type":"4"}},{"id":741880,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:23:25.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":4.12,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-26-000064","document":"wk-form4_1781213003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034026000064/wk-form4_1781213003.xml","form_type":"4"}},{"id":836507,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T20:46:41.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":3628,"price":4.2925,"value":15573.19,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the\n\"ESPP\"), for the ESPP purchase period of September 16, 2025 through March 15, 2026. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of\n1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended on March 15, 2026. The shares were acquired on the Purchase Date (as defined in the ESPP) of March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on\nthe Purchase Date of the relevant Offering Period."}],"balance_after":29598,"source":{"system":"sec-edgar","filing":"0001790340-26-000044","document":"wk-form4_1773780394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000044/wk-form4_1773780394.xml","form_type":"4"}},{"id":917254,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2026-02-05T13:44:51.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":176000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001790340-26-000034","document":"wk-form4_1770299088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000034/wk-form4_1770299088.xml","form_type":"4"}},{"id":917253,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2026-02-05T13:37:55.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":140000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001790340-26-000032","document":"wk-form4_1770298673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000032/wk-form4_1770298673.xml","form_type":"4"}},{"id":917252,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option","published_at":"2026-02-05T13:32:35.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":344000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":344000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":344000},"source":{"system":"sec-edgar","filing":"0001790340-26-000030","document":"wk-form4_1770298352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000030/wk-form4_1770298352.xml","form_type":"4"}},{"id":917251,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance, CAO"}}],"security":"Stock Option","published_at":"2026-02-05T13:22:31.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":140000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001790340-26-000026","document":"wk-form4_1770297748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000026/wk-form4_1770297748.xml","form_type":"4"}},{"id":917250,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2026-02-05T13:14:49.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":140000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001790340-26-000024","document":"wk-form4_1770297286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000024/wk-form4_1770297286.xml","form_type":"4"}},{"id":917851,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":35709,"kind":"person","name":"Zeskind Benjamin J.","position":1,"cik":"0001870062","reported_name":"Zeskind Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option","published_at":"2026-02-05T13:10:18.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":688000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":688000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":688000},"source":{"system":"sec-edgar","filing":"0001790340-26-000022","document":"wk-form4_1770297015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870062/000179034026000022/wk-form4_1770297015.xml","form_type":"4"}},{"id":917266,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67550,"kind":"person","name":"Matushansky Igor","position":1,"cik":"0001768208","reported_name":"Matushansky Igor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-05T08:27:29.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":140000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001790340-26-000028","document":"wk-form4_1770298047.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768208/000179034026000028/wk-form4_1770298047.xml","form_type":"4"}},{"id":933983,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2026-01-21T14:09:57.000Z","date":"2026-01-16","kind":"purchase","planned":false,"acquired":true,"shares":5250,"price":4.76,"value":24990.0,"ownership":{"direct":true},"balance_after":11050,"source":{"system":"sec-edgar","filing":"0001790340-26-000016","document":"wk-form4_1769004593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000016/wk-form4_1769004593.xml","form_type":"4"}},{"id":935305,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-20T14:17:29.000Z","date":"2026-01-15","kind":"purchase","planned":false,"acquired":true,"shares":21645,"price":4.6681,"value":101041.0245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.61 to $4.69. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":74530,"source":{"system":"sec-edgar","filing":"0001790340-26-000014","document":"wk-form4_1768918646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034026000014/wk-form4_1768918646.xml","form_type":"4"}},{"id":936694,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-01-16T21:07:43.000Z","date":"2026-01-15","kind":"purchase","planned":false,"acquired":true,"shares":2298,"price":4.57,"value":10501.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.57 to $4.571. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":376496,"source":{"system":"sec-edgar","filing":"0001790340-26-000012","document":"wk-form4_1768597660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000012/wk-form4_1768597660.xml","form_type":"4"}},{"id":938260,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-01-15T13:06:11.000Z","date":"2026-01-13","kind":"purchase","planned":false,"acquired":true,"shares":2626,"price":4.153,"value":10905.778,"ownership":{"direct":true},"balance_after":25970,"source":{"system":"sec-edgar","filing":"0001790340-26-000010","document":"wk-form4_1768482368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000010/wk-form4_1768482368.xml","form_type":"4"}},{"id":939295,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-14T13:10:34.000Z","date":"2026-01-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.3452,"value":86904.0,"ownership":{"direct":false,"nature":"General Partner of S4K Investments LLC."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.315 to $4.38. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":135441,"source":{"system":"sec-edgar","filing":"0001790340-26-000008","document":"wk-form4_1768396231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034026000008/wk-form4_1768396231.xml","form_type":"4"}},{"id":955175,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":27196,"kind":"person","name":"KEATING LAURIE","position":1,"cik":"0001620743","reported_name":"KEATING LAURIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-01-02T21:56:14.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":7888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the \"Compensation Program\"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service."}],"balance_after":7888,"derivative":{"exercise_price":6.58,"expiration_date":"2036-01-01","underlying":"Class A Common Stock","underlying_shares":7888},"source":{"system":"sec-edgar","filing":"0001790340-26-000004","document":"wk-form4_1767390971.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620743/000179034026000004/wk-form4_1767390971.xml","form_type":"4"}},{"id":955321,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-01-02T21:50:06.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":7888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the \"Compensation Program\"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service."}],"balance_after":7888,"derivative":{"exercise_price":6.58,"expiration_date":"2036-01-01","underlying":"Class A Common Stock","underlying_shares":7888},"source":{"system":"sec-edgar","filing":"0001790340-26-000002","document":"wk-form4_1767390602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034026000002/wk-form4_1767390602.xml","form_type":"4"}},{"id":1022288,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-10-07T12:56:12.000Z","date":"2025-10-03","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":6.67,"value":50025.0,"ownership":{"direct":true},"balance_after":156766,"source":{"system":"sec-edgar","filing":"0001790340-25-000127","document":"wk-form4_1759841769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034025000127/wk-form4_1759841769.xml","form_type":"4"}},{"id":1026382,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-02T13:02:58.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":6.39,"value":1917.0,"ownership":{"direct":true},"balance_after":27533,"source":{"system":"sec-edgar","filing":"0001790340-25-000125","document":"wk-form4_1759410175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000125/wk-form4_1759410175.xml","form_type":"4"}},{"id":1026383,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-02T12:57:31.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":6.3792,"value":5103.36,"ownership":{"direct":true},"balance_after":23344,"source":{"system":"sec-edgar","filing":"0001790340-25-000123","document":"wk-form4_1759409848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000123/wk-form4_1759409848.xml","form_type":"4"}},{"id":1026381,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Class A Common Stock","published_at":"2025-10-02T12:52:43.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":1020,"price":6.8299,"value":6966.498,"ownership":{"direct":true},"balance_after":4870,"source":{"system":"sec-edgar","filing":"0001790340-25-000121","document":"wk-form4_1759409561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000121/wk-form4_1759409561.xml","form_type":"4"}},{"id":1029480,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-10-01T12:59:40.000Z","date":"2025-09-30","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":7.0307,"value":52730.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.0049 to $7.055. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":149266,"source":{"system":"sec-edgar","filing":"0001790340-25-000119","document":"wk-form4_1759323577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034025000119/wk-form4_1759323577.xml","form_type":"4"}},{"id":1030628,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-30T13:00:58.000Z","date":"2025-09-29","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.18,"value":35900.0,"ownership":{"direct":true},"balance_after":141766,"source":{"system":"sec-edgar","filing":"0001790340-25-000117","document":"wk-form4_1759237255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034025000117/wk-form4_1759237255.xml","form_type":"4"}},{"id":1036963,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-17T20:41:20.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":11815,"price":1.428,"value":16871.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the \"ESPP\"), for the ESPP purchase period of March 16, 2025 through September 15, 2025. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Enrollment Date (as defined in the ESPP) of the relevant Offering Period."}],"balance_after":22544,"source":{"system":"sec-edgar","filing":"0001790340-25-000115","document":"wk-form4_1758141678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000115/wk-form4_1758141678.xml","form_type":"4"}},{"id":1036962,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-17T20:35:58.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":14497,"price":1.428,"value":20701.716,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the\n\"ESPP\"), for the ESPP purchase period of March 16, 2025 through September 15, 2025. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of\n1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on\nthe Enrollment Date (as defined in the ESPP) of the relevant Offering Period."}],"balance_after":27233,"source":{"system":"sec-edgar","filing":"0001790340-25-000113","document":"wk-form4_1758141356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000113/wk-form4_1758141356.xml","form_type":"4"}},{"id":1036961,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-17T20:30:19.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":14880,"price":1.428,"value":21248.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the\n\"ESPP\"), for the ESPP purchase period of March 16, 2025 through September 15, 2025. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of\n1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on\nthe Enrollment Date (as defined in the ESPP) of the relevant Offering Period."}],"balance_after":374198,"source":{"system":"sec-edgar","filing":"0001790340-25-000111","document":"wk-form4_1758141012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000111/wk-form4_1758141012.xml","form_type":"4"}},{"id":1091098,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39170,"kind":"person","name":"HAUSMAN DIANA","position":1,"cik":"0001563992","reported_name":"HAUSMAN DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-07T12:59:25.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.6245,"value":10873.5,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001790340-25-000098","document":"wk-form4_1751893158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563992/000179034025000098/wk-form4_1751893158.xml","form_type":"4"}},{"id":1091097,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39170,"kind":"person","name":"HAUSMAN DIANA","position":1,"cik":"0001563992","reported_name":"HAUSMAN DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-07T12:59:25.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":3.5956,"value":8989.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001790340-25-000098","document":"wk-form4_1751893158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563992/000179034025000098/wk-form4_1751893158.xml","form_type":"4"}},{"id":1091044,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-07-07T12:52:03.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":3.5695,"value":2498.65,"ownership":{"direct":true},"balance_after":10729,"source":{"system":"sec-edgar","filing":"0001790340-25-000096","document":"wk-form4_1751892717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000096/wk-form4_1751892717.xml","form_type":"4"}},{"id":1092699,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":35709,"kind":"person","name":"Zeskind Benjamin J.","position":1,"cik":"0001870062","reported_name":"Zeskind Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-03T13:12:08.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":7015,"price":3.5342,"value":24792.413,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.45 to $3.64. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":2312852,"source":{"system":"sec-edgar","filing":"0001790340-25-000094","document":"wk-form4_1751548321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1870062/000179034025000094/wk-form4_1751548321.xml","form_type":"4"}},{"id":1092698,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":35709,"kind":"person","name":"Zeskind Benjamin J.","position":1,"cik":"0001870062","reported_name":"Zeskind Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-03T13:12:08.000Z","date":"2025-07-01","kind":"purchase","planned":false,"acquired":true,"shares":2985,"price":3.3792,"value":10086.912,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.35 to $3.41. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":2305837,"source":{"system":"sec-edgar","filing":"0001790340-25-000094","document":"wk-form4_1751548321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870062/000179034025000094/wk-form4_1751548321.xml","form_type":"4"}},{"id":1099198,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-30T13:09:20.000Z","date":"2025-06-27","kind":"purchase","planned":false,"acquired":true,"shares":9500,"price":3.6619,"value":34788.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.6 to $3.73. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":52885,"source":{"system":"sec-edgar","filing":"0001790340-25-000089","document":"wk-form4_1751288953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034025000089/wk-form4_1751288953.xml","form_type":"4"}},{"id":1102314,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-24T13:01:43.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":6007,"price":2.4299,"value":14596.4093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.4101 to $2.4299. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":359318,"source":{"system":"sec-edgar","filing":"0001790340-25-000087","document":"wk-form4_1750770096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000087/wk-form4_1750770096.xml","form_type":"4"}},{"id":1102313,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-24T13:01:43.000Z","date":"2025-06-20","kind":"purchase","planned":false,"acquired":true,"shares":7415,"price":2.6999,"value":20019.7585,"ownership":{"direct":true},"balance_after":353311,"source":{"system":"sec-edgar","filing":"0001790340-25-000087","document":"wk-form4_1750770096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000087/wk-form4_1750770096.xml","form_type":"4"}},{"id":1102315,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-24T12:52:20.000Z","date":"2025-06-20","kind":"purchase","planned":false,"acquired":true,"shares":1900,"price":2.5285,"value":4804.15,"ownership":{"direct":true},"balance_after":5800,"source":{"system":"sec-edgar","filing":"0001790340-25-000085","document":"wk-form4_1750769533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000085/wk-form4_1750769533.xml","form_type":"4"}},{"id":1103952,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-23T13:09:57.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.5275,"value":63187.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.07 to $2.96. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":136766,"source":{"system":"sec-edgar","filing":"0001790340-25-000083","document":"wk-form4_1750684190.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034025000083/wk-form4_1750684190.xml","form_type":"4"}},{"id":1105154,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":35709,"kind":"person","name":"Zeskind Benjamin J.","position":1,"cik":"0001870062","reported_name":"Zeskind Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-20T13:09:33.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":21000,"price":2.3878,"value":50143.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.31 to $2.44. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":2302852,"source":{"system":"sec-edgar","filing":"0001790340-25-000081","document":"wk-form4_1750424967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870062/000179034025000081/wk-form4_1750424967.xml","form_type":"4"}},{"id":1106147,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-18T13:11:22.000Z","date":"2025-06-17","kind":"purchase","planned":false,"acquired":true,"shares":40485,"price":2.2052,"value":89277.522,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.16 to $2.24. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":43385,"source":{"system":"sec-edgar","filing":"0001790340-25-000079","document":"wk-form4_1750252275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034025000079/wk-form4_1750252275.xml","form_type":"4"}},{"id":1109455,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39170,"kind":"person","name":"HAUSMAN DIANA","position":1,"cik":"0001563992","reported_name":"HAUSMAN DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T13:21:28.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000075","document":"wk-form4_1750080081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563992/000179034025000075/wk-form4_1750080081.xml","form_type":"4"}},{"id":1109691,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T13:15:35.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000073","document":"wk-form4_1750079729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034025000073/wk-form4_1750079729.xml","form_type":"4"}},{"id":1109746,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":27196,"kind":"person","name":"KEATING LAURIE","position":1,"cik":"0001620743","reported_name":"KEATING LAURIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T13:09:20.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000071","document":"wk-form4_1750079353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620743/000179034025000071/wk-form4_1750079353.xml","form_type":"4"}},{"id":1109960,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T13:04:27.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000069","document":"wk-form4_1750079056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034025000069/wk-form4_1750079056.xml","form_type":"4"}},{"id":1110321,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39425,"kind":"person","name":"CARPENTER ROBERT J","position":1,"cik":"0001021046","reported_name":"CARPENTER ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T12:59:28.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000067","document":"wk-form4_1750078761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021046/000179034025000067/wk-form4_1750078761.xml","form_type":"4"}},{"id":1109524,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":55240,"kind":"person","name":"BERMAN ANN E","position":1,"cik":"0001349408","reported_name":"BERMAN ANN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T08:54:39.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000065","document":"wk-form4_1750078473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349408/000179034025000065/wk-form4_1750078473.xml","form_type":"4"}},{"id":1193081,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67550,"kind":"person","name":"Matushansky Igor","position":1,"cik":"0001768208","reported_name":"Matushansky Igor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-03-24T16:12:04.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 17, 2026 and then in equal monthly installments over the subsequent three years, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":118000,"derivative":{"exercise_price":1.8,"expiration_date":"2035-03-21","underlying":"Class A Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001790340-25-000049","document":"wk-form4_1742847116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768208/000179034025000049/wk-form4_1742847116.xml","form_type":"4"}},{"id":1278282,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2025-02-07T21:25:17.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":110000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001790340-25-000032","document":"wk-form4_1738963510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000032/wk-form4_1738963510.xml","form_type":"4"}},{"id":1278281,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2025-02-07T21:21:39.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":110000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001790340-25-000030","document":"wk-form4_1738963291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000030/wk-form4_1738963291.xml","form_type":"4"}},{"id":1278280,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2025-02-07T21:17:49.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":100000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001790340-25-000028","document":"wk-form4_1738963057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000028/wk-form4_1738963057.xml","form_type":"4"}},{"id":1278279,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":37578,"kind":"person","name":"Hall Brett Matthew","position":1,"cik":"0001870437","reported_name":"Hall Brett Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option","published_at":"2025-02-07T21:13:42.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":240000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001790340-25-000026","document":"wk-form4_1738962816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000026/wk-form4_1738962816.xml","form_type":"4"}},{"id":1278894,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":35709,"kind":"person","name":"Zeskind Benjamin J.","position":1,"cik":"0001870062","reported_name":"Zeskind Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option","published_at":"2025-02-07T21:10:23.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":480000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001790340-25-000024","document":"wk-form4_1738962616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870062/000179034025000024/wk-form4_1738962616.xml","form_type":"4"}},{"id":1278278,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2025-02-07T21:06:49.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":110000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001790340-25-000022","document":"wk-form4_1738962402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000022/wk-form4_1738962402.xml","form_type":"4"}},{"id":1318800,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-01-02T21:12:13.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":23485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the \"Compensation Program\"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service."}],"balance_after":23485,"derivative":{"exercise_price":2.2,"expiration_date":"2035-01-01","underlying":"Class A Common Stock","underlying_shares":23485},"source":{"system":"sec-edgar","filing":"0001790340-25-000007","document":"wk-form4_1735852326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000179034025000007/wk-form4_1735852326.xml","form_type":"4"}},{"id":1318611,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":27196,"kind":"person","name":"KEATING LAURIE","position":1,"cik":"0001620743","reported_name":"KEATING LAURIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-01-02T21:06:31.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":23485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the \"Compensation Program\"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service."}],"balance_after":23485,"derivative":{"exercise_price":2.2,"expiration_date":"2035-01-01","underlying":"Class A Common Stock","underlying_shares":23485},"source":{"system":"sec-edgar","filing":"0001790340-25-000005","document":"wk-form4_1735851984.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620743/000179034025000005/wk-form4_1735851984.xml","form_type":"4"}},{"id":1318372,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":55240,"kind":"person","name":"BERMAN ANN E","position":1,"cik":"0001349408","reported_name":"BERMAN ANN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-01-02T16:19:29.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":17614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Pursuant to the Compensation Program, the reporting person elected to receive this stock option in lieu of receiving the cash COB Retainer (as defined in the Compensation Program)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) serving as Chair of the Board (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service."}],"balance_after":17614,"derivative":{"exercise_price":2.2,"expiration_date":"2035-01-01","underlying":"Class A Common Stock","underlying_shares":17614},"source":{"system":"sec-edgar","filing":"0001790340-25-000009","document":"wk-form4_1735852761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349408/000179034025000009/wk-form4_1735852761.xml","form_type":"4"}},{"id":1318371,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":55240,"kind":"person","name":"BERMAN ANN E","position":1,"cik":"0001349408","reported_name":"BERMAN ANN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-01-02T16:19:29.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":23485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the \"Compensation Program\"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service."}],"balance_after":23485,"derivative":{"exercise_price":2.2,"expiration_date":"2035-01-01","underlying":"Class A Common Stock","underlying_shares":23485},"source":{"system":"sec-edgar","filing":"0001790340-25-000009","document":"wk-form4_1735852761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349408/000179034025000009/wk-form4_1735852761.xml","form_type":"4"}},{"id":1404421,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:09:02.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":4458,"price":1.6235,"value":7237.563,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the \"ESPP\"), for the ESPP purchase period of March 15, 2024 through September 15, 2024. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Enrollment Date (as defined in the ESPP) of March 15, 2024."}],"balance_after":12736,"source":{"system":"sec-edgar","filing":"0001790340-24-000071","document":"wk-form4_1726603736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034024000071/wk-form4_1726603736.xml","form_type":"4"}},{"id":1480463,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T20:26:02.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":8588,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":8588},"source":{"system":"sec-edgar","filing":"0001628280-24-028072","document":"wk-form4_1718310353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000162828024028072/wk-form4_1718310353.xml","form_type":"4"}},{"id":1480664,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":27196,"kind":"person","name":"KEATING LAURIE","position":1,"cik":"0001620743","reported_name":"KEATING LAURIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T20:22:53.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001628280-24-028065","document":"wk-form4_1718310166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620743/000162828024028065/wk-form4_1718310166.xml","form_type":"4"}},{"id":1481225,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39425,"kind":"person","name":"CARPENTER ROBERT J","position":1,"cik":"0001021046","reported_name":"CARPENTER ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T20:21:22.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001628280-24-028061","document":"wk-form4_1718310074.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021046/000162828024028061/wk-form4_1718310074.xml","form_type":"4"}},{"id":1480894,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39312,"kind":"person","name":"Feinberg Peter","position":1,"cik":"0001870076","reported_name":"Feinberg Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T20:20:14.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001628280-24-028057","document":"wk-form4_1718310005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870076/000162828024028057/wk-form4_1718310005.xml","form_type":"4"}},{"id":1480254,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39170,"kind":"person","name":"HAUSMAN DIANA","position":1,"cik":"0001563992","reported_name":"HAUSMAN DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T20:16:51.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001628280-24-028052","document":"wk-form4_1718309804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563992/000162828024028052/wk-form4_1718309804.xml","form_type":"4"}},{"id":1480310,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":55240,"kind":"person","name":"BERMAN ANN E","position":1,"cik":"0001349408","reported_name":"BERMAN ANN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T16:18:02.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001628280-24-028054","document":"wk-form4_1718309874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349408/000162828024028054/wk-form4_1718309874.xml","form_type":"4"}},{"id":1503136,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":93000,"derivative":{"exercise_price":3.01,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503135,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":0,"derivative":{"exercise_price":6.09,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503134,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":143000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":143000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":143000},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503133,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":143000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":143000},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503132,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":47300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":47300,"derivative":{"exercise_price":3.01,"expiration_date":"2032-02-09","underlying":"Class A Common Stock","underlying_shares":47300},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503131,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":47300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":0,"derivative":{"exercise_price":9.66,"expiration_date":"2032-02-09","underlying":"Class A Common Stock","underlying_shares":47300},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503130,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":101116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on July 15, 2022 and then in equal monthly installments over the subsequent three years, subject to Mr. Bookman's continued employment through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":101116,"derivative":{"exercise_price":3.01,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":101116},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503129,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67549,"kind":"person","name":"Bookman Michael","position":1,"cik":"0001840339","reported_name":"Bookman Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER, SECRETARY"}}],"security":"Stock Option","published_at":"2024-05-23T20:20:04.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on July 15, 2022 and then in equal monthly installments over the subsequent three years, subject to Mr. Bookman's continued employment through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share.  Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."}],"balance_after":0,"derivative":{"exercise_price":15,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":101116},"source":{"system":"sec-edgar","filing":"0001628280-24-024953","document":"wk-form4_1716495592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024953/wk-form4_1716495592.xml","form_type":"4"}},{"id":1503149,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":72000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503148,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503147,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":60500,"derivative":{"exercise_price":3.01,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503146,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":0,"derivative":{"exercise_price":6.09,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503145,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable (subject to continued service to the Issuer through the applicable vesting date) in forty-eight (48) equal monthly installments following the vesting commencement date of July 1, 2023, and will be fully vested and exercisable on July 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-06-13","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503144,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable (subject to continued service to the Issuer through the applicable vesting date) in forty-eight (48) equal monthly installments following the vesting commencement date of July 1, 2023, and will be fully vested and exercisable on July 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":9.55,"expiration_date":"2033-06-13","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503143,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on July 31, 2022, and will be fully vested and exercisable on June 30, 2026."}],"balance_after":5000,"derivative":{"exercise_price":3.01,"expiration_date":"2032-06-30","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503142,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on July 31, 2022, and will be fully vested and exercisable on June 30, 2026."}],"balance_after":0,"derivative":{"exercise_price":5.41,"expiration_date":"2032-06-30","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503141,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":23850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026."}],"balance_after":23850,"derivative":{"exercise_price":3.01,"expiration_date":"2032-02-10","underlying":"Class A Common Stock","underlying_shares":23850},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503140,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":9.66,"expiration_date":"2032-02-10","underlying":"Class A Common Stock","underlying_shares":23850},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503139,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":10000,"derivative":{"exercise_price":3.01,"expiration_date":"2032-08-11","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503138,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.33,"expiration_date":"2032-08-11","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503128,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:15:49.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":60500,"derivative":{"exercise_price":3.01,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024943","document":"wk-form4_1716495333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024943/wk-form4_1716495333.xml","form_type":"4"}},{"id":1503127,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:15:49.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":0,"derivative":{"exercise_price":6.09,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024943","document":"wk-form4_1716495333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024943/wk-form4_1716495333.xml","form_type":"4"}},{"id":1503126,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:15:49.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on January 23, 2024 and then in equal monthly installments over the subsequent three years, subject to Mr. Brakewood's continued employment through each applicable vesting date."}],"balance_after":165000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-03-31","underlying":"Class A Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001628280-24-024943","document":"wk-form4_1716495333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024943/wk-form4_1716495333.xml","form_type":"4"}},{"id":1503125,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67548,"kind":"person","name":"Brakewood Harold Eugene","position":1,"cik":"0001969578","reported_name":"Brakewood Harold Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:15:49.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on January 23, 2024 and then in equal monthly installments over the subsequent three years, subject to Mr. Brakewood's continued employment through each applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.71,"expiration_date":"2033-03-31","underlying":"Class A Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001628280-24-024943","document":"wk-form4_1716495333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024943/wk-form4_1716495333.xml","form_type":"4"}},{"id":1503124,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2024-05-23T20:14:30.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":60500,"derivative":{"exercise_price":3.01,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024939","document":"wk-form4_1716495251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024939/wk-form4_1716495251.xml","form_type":"4"}},{"id":1503123,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2024-05-23T20:14:30.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":0,"derivative":{"exercise_price":6.09,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024939","document":"wk-form4_1716495251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024939/wk-form4_1716495251.xml","form_type":"4"}},{"id":1503122,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2024-05-23T20:14:30.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":105000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001628280-24-024939","document":"wk-form4_1716495251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024939/wk-form4_1716495251.xml","form_type":"4"}},{"id":1503121,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2024-05-23T20:14:30.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001628280-24-024939","document":"wk-form4_1716495251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024939/wk-form4_1716495251.xml","form_type":"4"}},{"id":1503120,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2024-05-23T20:14:30.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":88600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on October 17, 2023 and then in equal monthly installments over the subsequent three years, subject to Ms. Neufeld's continued employment through each applicable vesting date."}],"balance_after":88600,"derivative":{"exercise_price":3.01,"expiration_date":"2032-10-31","underlying":"Class A Common Stock","underlying_shares":88600},"source":{"system":"sec-edgar","filing":"0001628280-24-024939","document":"wk-form4_1716495251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024939/wk-form4_1716495251.xml","form_type":"4"}},{"id":1503119,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":59755,"kind":"person","name":"Neufeld Leah R","position":1,"cik":"0001950673","reported_name":"Neufeld Leah R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option","published_at":"2024-05-23T20:14:30.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":88600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the underlying shares on October 17, 2023 and then in equal monthly installments over the subsequent three years, subject to Ms. Neufeld's continued employment through each applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":13.85,"expiration_date":"2032-10-31","underlying":"Class A Common Stock","underlying_shares":88600},"source":{"system":"sec-edgar","filing":"0001628280-24-024939","document":"wk-form4_1716495251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024939/wk-form4_1716495251.xml","form_type":"4"}},{"id":1549987,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":398600,"price":2.9,"value":1155940.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Represents (i) 955,689 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 1,939,584 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":2895273,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549986,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":280,"price":2.97,"value":831.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents (i) 1,086,227 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,646 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3293873,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}}],"next_cursor":"2024-04-03T21:37:04.000000Z,1549986"}